See also this year's filing and all EDGAR filings for this company.
PDF Report 0001677077_2023_Alzamend_Neuro_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001677077, Alzamend Neuro Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 14,413,534 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 102,909 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 1,164,932 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,118,221 |
| 9 | ResearchAndDevelopmentExpense | 5,201,314 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -42,524 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 14,516,443 |
| 1 | Liabilities | 1,164,932 |
| 2 | Expenses | 12,319,535 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 13,351,511 |
| 5 | NetIncome | -12,362,059 |
| 6 | ComprehensiveNetIncome | -12,362,059 |
| 7 | BaseVar | 14,021,717 |
| 8 | EconomicCapitalRatio | 1.35 |